Rankings
▼
Calendar
BHVN Q3 2018 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$55M
Net Income
-$61M
EPS (Diluted)
$-1.53
QoQ Revenue Growth
NaN%
Balance Sheet
Total Assets
$195M
Total Liabilities
$129M
Stockholders' Equity
$66M
Cash & Equivalents
$168M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$55M
-$40M
-38.8%
Net Income
-$61M
-$43M
-43.2%
← Q2 2018
All Quarters
Q1 2019 →